Brief: Caplin Point Laboratories Says USFDA Completed Gmp And Pai Inspection Of Unit Caplin Steriles Sterile Injectable Site
01/06/2023 06:20
June 1 (Reuters) - Caplin Point Laboratories Ltd
CAPL.NS :
* USFDA COMPLETED GMP AND PAI INSPECTION OF UNIT CAPLIN
STERILES
STERILE INJECTABLE SITE, GUMMIDIPOONDI
* AT END OF INSPECTION, FOUR OBSERVATIONS BY US FDA
* OBSERVATIONS ARE PROCEDURAL IN NATURE
Source text for Eikon: ID:nBSE2mrDt7
Further company coverage: CAPL.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees